June 17, 2022
In this episode, Michael Matson, analyst at Needham, explains his thoughts behind a possible J&J acquisition of Boston Scientific. He also explains why he...
01:19:27
November 12, 2015
For a man who took a private company from $17 million in sales to a $4.5 billion publicly traded juggernaut, John Brown is a...
00:18:09
March 26, 2021
Hologic CEO Steve MacMillan says last March he didn’t appreciate how COVID-19 would change the world forever. But the diagnostics company quickly rose to...
01:17:04